Apidra Children & Adolescents Study

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

INSULIN GLULISINE

Pharmaceutical form: solution for injection Route of administration: subcutaneous Dose regimen: once a day

DRUG

INSULIN GLARGINE

Pharmaceutical form:solution for injection Route of administration: subcutaneous Dose regimen: 0-15 minutes before meal or within 20 minutes from the start of meal according to prandial plasma glucose values

Trial Locations (1)

Unknown

Administrative office, Moscow

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY